Reddit Posts
$PPBT in my buying range again.
PPBT- a solid biotech company to invest in. 500% 1 year forecast.
Is the AMC, BB, KOSS run over? PPBT, TLRY, SNDL Short Squeeze
Just took my $AMC profits to $PPBT. Two NT-219 presos on Friday. Cancer play that all the vulture funds have naked shorted for the last year.
Called this three days ago...$PPBT setup for a breakout.
$PPBT #coiled for Saturday’s NT219 readout. Watch out for a possible leading gapper Monday (15m float)
$PPBT 4h chart setting up nicely for Saturday’s potential catalyst(s)
Gold and Silver pennystocks — 100 baggers, and the train is departing the station.
Trending Stocks on r/pennystocks
$PPBT — Visual of what is about to go down this week. Coincides with post below
PPBT — Potential 1000% runner, presenting BOMBSHELL CANCER DATA. 15m float 70m Market Cap and trading at cash value.
Mentions
PPBT thoughts? Closed up almost 82% today. Not very much convo on here about it. Volume yesterday was 190k, today over 400m.
I sure hope so. I bought in Monday at $0.59, was up over 100% a good chunk of the morning. I believe it’s got room to run if it can just keep momentum. Seems crazy that there’s still hardly mention of PPBT anywhere after today.
Do we think PPBT may rocket overnight and premarket tomorrow?? Or is it done
Same… I had it locked in for $2 a share and opted not to buy…. Instead I bought PPBT which is in red
if PPBT breaks $1.03 i think next retests are 1.05, 1.08 @ vwap, and after that, 1.10-1.20 IF it can break with strength
Yup I take that back, after watching PPBT's chart it's not looking good with that red dong
PPBT if it can hold this $1 range can see crazy highs. Just look at the chart, no need to invest immediately, see if you like it.
PPBT looks primed to break out
Just take a look at the graph of PPBT. It ran crazy pre market. Holding strong in market. I have high hopes for post market.
Look at PPBT, just broke $1. It had highs earlier in the morning. This is the only green in this Red Sea. I’m in at a 0.99, PT is 1.20>1.40>2.0. Just needs nice breaks and can see crazy upside.
PPBT rising fast!!! this is fun
Could PPBT be the next huge climber?
During HALT PPBT volume increased
Made some quick profit with PPBT, got out at $1.36. I will check back later today.
Don't FOMO into PPBT or get greedy and hold it. The news today about manufacturing isn't worth a doubling of price. The company just diluted a month ago and with only $5.6 million cash they will need to dilute again within 6-9 months (their own press release says their cash runway is to Q3 2026)
PPBT: Going parabolic...over 225 million volume
PPBT: https://www.tipranks.com/news/company-announcements/purple-biotech-reaches-manufacturing-milestone-for-im1240-antibody?utm_source=robinhood.com&utm_medium=referral
CMBM and PPBT both have more room to run I bought both
PPBT more upside than CMBM from here
My plays....back in CMBM and looking for a good entry point for PPBT before 9:30
FGL PPBT both have lots of volume with low floats
$PPBT just got confirmed development on their clinical trials for a special antibody. Insider candle spiked a week ago. Can see this pump today.
At least you broke even! Good catch on the fall. I lost over 50% of my investment when PPBT split 😭. there will be huge loses on this one for a lot of people.
SELL 1st thing tomorrow. This stock will tank hard. It’s down 88% ytd and that’s with that past week’s gains. Down 52.99% after market. The past week’s gains will likely be wiped out in pre-market tomorrow. I bought PPBT right before their r/s. Lost hard and fast 😡 then held thinking it would bounce back at least a tiny bit. Nope. Still falling harder
PPBT looking for 3.50
$PPBT Purple Biotech Reports Final Data from Phase 2 Study of CM24 in Pancreatic Cancer Patients at AACR 2025 Annual Meeting: Improved Outcomes and Significant Efficacy in Biomarker-Enriched Subgroups.
If my funds weren’t tied into BURU and SPGC I’d look at PPBT https://www.stocktitan.net/news/PPBT/purple-biotech-granted-new-u-s-patent-for-nt219-in-combination-with-386wani1zrv9.html They just secured a patent
Damn, missed out on the PPBT news this morning, could've made some easy money. That $8 to $0.4 dip in September still looks scary tho.
Gotchu! RUM: Rumble Inc. (RUM) is showing strong bullish momentum, with the current price at $6.49, significantly above its 10-day SMA of $5.84 and 20-day EMA of $5.72, indicating a robust upward trend. The RSI values are in the overbought territory, suggesting potential for a pullback, but the MACD histogram remains positive, supporting continued upward movement. Recent trading volumes have been high, reflecting increased investor interest, although today's volume is currently at zero, which could indicate a pause or consolidation phase. Given the broader market's cautious optimism and RUM's recent price action, a long position could be considered with an entry around $6.45. Set the first price target at $6.80 and a second at $7.00, with a stop loss at $6.30 to manage downside risk. Confidence in reaching the first target is moderate due to strong technical indicators, while the second target carries lower confidence given potential resistance and overbought conditions. Keep an eye on any emerging news that could impact sentiment or trading volumes. DJT: Trump Media & Technology Group Corp. (DJT) has experienced a significant rally, with its current price at $52.41, driven by the launch of its Truth+ streaming service and speculation around Donald Trump's 2024 presidential prospects. The stock's RSI values are extremely high, indicating overbought conditions, while the MACD histogram suggests strong bullish momentum. Recent trading volumes have been substantial, reflecting heightened investor interest, yet the speculative nature of the stock due to its dependency on political outcomes warrants caution. Given the broader market's cautious optimism and DJT's recent performance, a long position could be considered with an entry around $51.50. Set a first price target at $55.00 with a confidence level of 70%, and a second target at $58.00 with a 60% confidence level, given the potential for continued speculative buying. A stop loss should be placed at $48.00 to mitigate downside risk, considering the stock's volatility and external uncertainties. PPBT: Purple Biotech Ltd. (PPBT) is currently trading at $3.40, showing a significant decline from its recent highs around $5.50, indicating strong bearish momentum. The 14-day RSI is at 32.65, suggesting the stock is nearing oversold territory, but not yet signaling a reversal. The MACD histogram is slightly positive, hinting at potential short-term stabilization, but the overall trend remains negative with both SMA and EMA values above the current price. Given the lack of recent news and low trading volume compared to its 65-day average, market interest appears subdued. In the broader market context, while SPY and QQQ show resilience, PPBT's biotech sector may not benefit from this optimism due to its specific challenges. For today's session, consider entering a short position around $3.45, with a first target at $3.20 and a second target at $3.00, setting a stop loss at $3.60. Confidence in reaching the first target is moderate due to the prevailing bearish sentiment, while the second target carries lower confidence given potential support near $3.20. SVRE: SaverOne 2014 Ltd. (SVRE) is currently trading at $1.59, showing a significant decline from its recent highs, with technical indicators suggesting bearish momentum. The RSI values are below 35, indicating oversold conditions, while the MACD remains negative, reinforcing the downtrend. The stock's 10-day SMA ($2.01) and 20-day EMA ($2.18) are well above the current price, highlighting potential resistance levels. Despite the broader market's cautious optimism, SVRE's low volume and lack of recent news suggest limited buying interest. Given these factors, a short position could be considered with an entry around $1.60. Target the first price at $1.50 and a second at $1.40, with a stop loss at $1.70 to manage risk. Confidence in reaching the first target is moderate due to the oversold RSI, while the second target carries lower confidence given potential support near $1.50. WINT: Windtree Therapeutics, Inc. (WINT) is currently trading at $0.8216, showing a significant decline from its 30-day SMA of $1.5675, indicating bearish momentum. The RSI values are below 40, suggesting the stock is oversold, yet the MACD histogram is positive, hinting at potential short-term bullish divergence. However, the lack of recent news and current volume suggests limited immediate catalysts for a reversal. Given the broader market's cautious optimism and WINT's weak technical indicators, a short position could be considered. Enter at $0.82, with a first target of $0.75 and a second target of $0.70, setting a stop loss at $0.85. Confidence in reaching the first target is moderate due to oversold conditions, while the second target has lower confidence given potential support levels. Monitor for any unexpected news or volume spikes that could alter this outlook.
RUM, DJT, PPBT, SVRE, WINT, ILLR thanks man!
I am positioned in FGEN and PPBT for their reveal of results at annual ASCO meeting. FGEN got a nice reverse head and shoulders pattern on the daily and I believe they bring good results!
PPBT aka KITOV. Fuck you Isaac
PPBT...I played the stupid game and won the stupid prize, but I'm not selling.
💰💰💰Get new runners! #premarket #watchlist 07/11 \*Full watchlist in app $GDTC (+178%), $CING (+45%) $BTTX (+34%), $PPBT (+34%) https://preview.redd.it/7i57bgnk1cbb1.jpeg?width=576&format=pjpg&auto=webp&s=7ffb954dc787ac2e0b3daffe3159166120e764f1
💰💰💰Get new runners in our app! #premarket #watchlist 07/11 \*Full watchlist in app $GDTC (+178%), $CING (+45%) $BTTX (+34%), $PPBT (+34%) https://preview.redd.it/e5hy50fg1cbb1.jpeg?width=576&format=pjpg&auto=webp&s=e56c0e84224bf6e614320402d08071634c109bea
ATLX - It used to be a lithium penny stock but recently uplifted to the NASDAQ. They reverse split to get there of course, and landed at around $6.50. A few months later, they're now around the $18.00 mark and lots of potential to go higher still. PPBT - This one has got a bit of a bad rap in the past, but the bottom line is they have multiple cancer drugs in successful stage II trials and a lot of big pharma partnerships like Bristol Myers, Merck, and MD Anderson. It's been a slow burn but I think 2023 is the year PPBT takes off in a big way.
PPBT big news expected in Q2 - Q3. $9 will get you 3 shares and a Coke right now.
I am a bot from /r/wallstreetbets. You submitted one or more banned tickers: PPBT. Message /u/zjz if they're above 500 million-ish market cap and not related to crypto/pennies/OTC.
$PPBT The new cancer drug cocktail additive that limits the diseases resistance to popular treatments. This means that drugs can be given in less toxic doses, and that more effective doses can be applied with less toxicity. It can go lower, and you could lose it all, but if the drugs continue on their path (currently phase 2) you could easily see a 1000% return. It’s likely an all or nothing okay. You’ll easily lose half, if your timing is off or the drugs prove ineffective.
$PPBT, previously $KTOV If you already have a background In bio/pharma, you should take a close look at market cap. They are presenting at AACR next week and I’d bet my last dollar they have news. It’s been delayed for a long times, and neither of their drugs have shown any toxicity in humans. They are actively shrinking tumors by synergizing with other flagship treatments in cocktail. If you haven’t messed with Bio/pharma much, you’ll likely be flying in the dark, and may have trouble timing an exit as it pops. If you’re on stocktwits, check out a guy named Brad lasance or “blasance”. The dudes done alot of DD and I’ve adopted his research style in my other bio plays. Also, wade through the salt from folks who were burned when it was KTOV. The drugs appear to be the real deal. That’s what matters. If you have an oncologist friends, talk to them about therapies that use the immune system to target cancer. See what they say.
PPBT. Pharmaceutical company and they focus on cancer research. In clinical trials with a few drugs, so far decently promising. Phase 2 coming soon. I don't think they'll cure cancer per say, but possibly by themselves or in conjunction with other drugs they might be able to make a little bit of a difference, and that's a win for everyone.
Not German, and it’s pharma instead of straight biotech, but… and don’t shoot me: $PPBT (aka Kitov, before rebranding) Avoid Stocktwits and other hyper-bullish forums. Instead, read all media available (not a huge amount) both good and bad, and tell me if you don’t think they are destined for licensing. All bulls are shouting “Buyout!”, but are missing the golden goose scenario right in front of them. It may very well sell, but I’m betting on licensing deals to add their drugs to existing flagship cocktails. Specifically, Glioblastoma and aggressive small cell cancer. Read carefully. Avoid amateur opinions until AFTER you’re up to speed on their drugs, and the most up-to-date interim results.
You should add PPBT to the list that includes options.
It could squeeze, but do consider that alot of the shorting is likely market makers manipulating the price for their benefit. Rolling out of the shorts is likely well accounted for in their plans, and while I realize this sounds conspiratorial, could very well be being informed by insiders at PPBT. I would advise people not to buy looking for squeeze. Buy in if you like the drugs they are developing.
I’ve been adding to my position for years. I’ve been in since long before the name change. Yes, there is short term value to be gained, but I’m holding out for NT-219’s long term potential, be that licensing or buyout. Everyone is predicting a buyout, but truly, I’d rather see thing stay in-house and license this drug into every cancer and immune disease drug cocktail in existence. I personally believe it could be one of the major tools for advancing our power over cancer in our lifetime. Take everything I’m saying with a grain of salt. I’m a permabull for PPBT as long as they hold NT-219. I’ve not sold a single share for almost 3 years.
Google “nt-219” It’s a cancer drug. Buy 50k PPBT shares. You’re in at the bottom, you’re either gonna turn 50k into 25k or 1m+ in 12-24 months. If you end up with 1m+ you might even survive your fuckin cancer. If you end up with 25k….fuck it, you’re outta here anyway
Your post with title "PPBT To the moon on Wednesday 11/17" has been automatically removed from r/PennyStocks for being low-effort/spam. (Low word count) probably by u/automod *I am a bot, and this action was performed automatically. Please [contact the moderators of this subreddit](/message/compose/?to=/r/pennystocks) if you have any questions or concerns.*
$PPBT. Kitov bag holders about to get paid when nt-219 gets trial data.
$PPBT. Look at that tight wedge. Nothing but positive early stage results from trials on the drug as well. It was previously $KTOV and burned investors in the past. I’m betting on the drug, not the management. I stress **betting**. I’ve parked some cash I can afford to lose in it, and am leaving it alone until final phase results for nt-219 (or buyout, but I think we are headed for licensing instead of a buyout) Full disclosure; I’m really biased toward Biotech/pharma because I swing trade it constantly. My suggestion is to park the money in something you believe in or use often. I haven’t played call of duty since MW2 but you better believe I’ve been buying Activision all the way down. That’s good for a 2x in a few years. Real estate is another area I have experience/knowledge of so I also trade REITs. Find something you understand that has a share price that’s hurting. Find out why. Invest in the ones you have strong reason to believe will overcome the negative conditions.
$PPBT Top line data for their blockbuster cancer drugs expected by end of year. Lots of connections point to a collaboration or buyout with Bristol Myers.
More of a mid to long-term play, but check out Purple Biotech (PPBT). Ridiculously low market cap given the drugs they have coming up in their pipeline (plus having no debt).
Ticker: PPBT Last Close: $4.96 Market Cap: 86.13M Working in collaboration with Bristol-Myers Squibb (BMS) on CM24, for treating multiple advanced cancers. Another drug of theirs, NT219, targets "advanced solid tumors and head and neck cancer." It has thus far had a complete remission of a target tumor and a non-target tumor in the lowest dosage level of phase 1-2 clinical trials. They have had great results so far and still seem to be flying under the radar. Could be worth a look.
**Ticker Added PPBT** Spam: True Last Seen Market Cap: 0.0 Is SPAC: False Common Word: False
$NGAC $PPBT Please and thank you. I would love someone else’s insight.
More than I should in PPBT with a hope of a better cancer treatment or cure?
PPBT UP 5.26% to $5.20. Golden Cross!!
PPBT Diamond Hands…🚀🚀🚀VERY soon! ARK ETF from 73K shares to 725K in past 10 days!
PPBT DON’t fucking buy it. I need more cheap.
PPBT Added by cathy Woods to the ARK fund! She is the new warren Buffett and does not lose
PPBT MOON THIS WEEK!!! By now at a tremendous discount. 🌕🌕🌕🌕🌕🌕🌕🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀. $50 EOY!
If interested in Pharma, I'd suggest looking in to Purple Biotech (PPBT) - it is trading right meow at $4.70 and if bought out and that appears to eventually happen, the price could make for some decent profit. My family got me in to it and lots of good news surrounding it so I'd reckon worth a mention here.
PPBT cancer drug in human trials showed complete remission at the lowest dose. Should be getting higher dose data any day now.
PPBT has two amazing cancer fighting drugs in trials and preliminary human data was outstanding (complete remission). Rumor of a partnership/licensing deal in the short-term, but long-term their drugs NT-219 and CM-24 are potential game changers when it comes to cancer treatment.
Cure cancer and fill my bags. PPBT LFG!
Glad I didn’t buy PPBT Friday afternoon. Getting destroyed right now
Check out $PPBT, about to go parabolic on cancer treatment data releasing today. Thank me later.
PPBT Google their drug nt219 10 bagger, baby! Don’t fomo later.
**PPBT - Purple Biotech** [BIG CATALYST LATER TODAY](https://pbs.twimg.com/media/E2efTu2XoAEOaJ3?format=jpg&name=900x900)
PPBT should be on there too. This cancer squeeze is gonna be legendary.
It’s biotech time PPBT for their cancer data
PPBT Revolutionary cancer medication. Market cap only 100m it’s worth 1B
ATOS is getting a lot of love, but PPBT is the sleeper you gotta watch. Data dropping tomorrow
PPBT If you remember KTOV from last year, she’s back. New and improved. Data drops tomorrow. Get in pre-market
Your post with title "PPBT set for big run tomorrow morning with positive clinical trial readout. $8+" has been automatically removed from r/PennyStocks for being low-effort/spam. (Low word count) probably by u/automod *I am a bot, and this action was performed automatically. Please [contact the moderators of this subreddit](/message/compose/?to=/r/pennystocks) if you have any questions or concerns.*
PPBT to the moon tomorrow. EZ Clap.
$PPBT NT-219 preclinical data is some of the best that we have ever seen. 4x as strong as erbitux and 2x as strong as keytruda. Human Data drops Friday.
$PPBT abstract for data that’s coming on Friday…let’s go! https://cancerres.aacrjournals.org/content/80/16_Supplement/5639
$PPBT NT-219 has the potential to be the strongest cancer drug ever. And we get to see it’s first round of data on Friday. Tiny market cap and super low float…going to skyrocket tomorrow and Friday.
$PPBT NT-219 data on Friday…low float locked up already with longs HODLing for 100+ https://stocktwits.com/Kingjake26/message/338296350